The immunophenotype of ZNF384-rearranged B-ALL is characterized by negative or weak expression of CD10 and aberrant expression of CD13 and/or CD33 [78,80]. This evidence concerns the gene ZNF384 and precursor B-cell acute lymphoblastic leukemia.